Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M314148200 on April 9, 2004

J. Biol. Chem., Vol. 279, Issue 26, 27278-27285, June 25, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/26/27278    most recent
M314148200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacDonald, M. J.
Right arrow Articles by Baker, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacDonald, M. J.
Right arrow Articles by Baker, T. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Immunochemical Identification of Coenzyme Q0-Dihydrolipoamide Adducts in the E2 Components of the {alpha}-Ketoglutarate and Pyruvate Dehydrogenase Complexes Partially Explains the Cellular Toxicity of Coenzyme Q0*

Michael J. MacDonald{ddagger}§, Rhonda D. Husain¶, Susanne Hoffmann-Benning¶, and Tracie R. Baker{ddagger}

From the {ddagger}Childrens Diabetes Center, University of Wisconsin Medical School, Madison, Wisconsin 53706 and Mass Spectrometry Facility, Michigan State University, East Lansing, Michigan 48824

Coenzyme Q0 (Q0), a strong electrophile, is toxic to insulin-producing cells. Q0 was incubated with rat and human pancreatic islets and INS-1 insulinoma cells, and its attachment to cellular proteins was studied with Western analysis using antiserum raised against the benzoquinone ring structure of ubiquinone (anti-Q). Q0 covalently bonded to two proteins, one of 50 kDa and another of 70 kDa. Both proteins were found to be mitochondrial in human and rat islet cells and in many rat organs. Mitochondria were incubated with Q0, and affinity-purified anti-Q was used to immunoprecipitate the 50-kDa protein. Amino acid sequencing identified it as dihydrolipoamide succinyltransferase, the E2 component of the {alpha}-ketoglutarate dehydrogenase complex (KDC). Western analysis also showed that Q bonds to the E2 components of the purified KDC and 0the pyruvate dehydrogenase complex (PDC). Dihydrolipoamide acetyltransferase, the E2 of the PDC, has a molecular mass of 70 kDa, and the 70-kDa protein was inferred to be this enzyme. Q0 was found to bond only to proteins containing dihydrolipoate, and in preparations of mitochondria, thiol reducing agents facilitated the attachment of Q0, but oxidizing agents prevented it, suggesting that Q0 bonds to thiols of dihydrolipoamide. Incubation of human or pig PDC with Q0 followed by matrix-assisted laser desorption ionization time-of-flight and liquid chromatography/electrospray ionization mass spectrometry analyses of chymotrypsin-digested peptides of PDC E2 confirmed that Q0 bonds to the dihydrolipoamide in these proteins. In mitochondria, coenzymes Q1 and Q2 did not bond to the 50-kDa protein but competed with the bonding of Q0 to this protein. The prevention by Q1 of characteristics the bonding of Q0 to KDC E2, as well as other of the Q0 effect, are reminiscent of the action of Q0 on the mitochondrial permeability transition pore described previously (Fontaine, E., Ichas, F., and Bernardi, P. (1998) J. Biol. Chem. 273, 25734–25740).


Received for publication, December 24, 2003 , and in revised form, April 9, 2004.

* This study was supported by National Institutes of Health Grant DK28348, the Oscar C. Rennebohm Foundation, and the Robert Wood Johnson Family Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Rm. 3459 Medical Science Center, 1300 University Ave., Madison, WI 53706. Tel.: 608-262-1195; Fax: 608-262-9300; E-mail: mjmacdon{at}wisc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. K. Scott, C. Atsriku, P. Kaminker, J. Held, B. Gibson, M. A. Baldwin, and C. C. Benz
Vitamin K3 (Menadione)-Induced Oncosis Associated with Keratin 8 Phosphorylation and Histone H3 Arylation
Mol. Pharmacol., September 1, 2005; 68(3): 606 - 615.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement